Several findings suggested cardioprotection in ACE inhibitors/angiotensin receptor antagonists and β‐blockers, but strong conclusion cannot be made because several of these studies suffered from significant limitations (e.g., borderline significance of the findings, small declines in systolic function in the ANT‐only group, and examinations performed under effect of drugs with significant direct hemodynamic activity).
← all excerpts
Comprehensive review of cardiovascular toxicity of drugs and related agents.
1
—
—